Drug manufacturer to pay Massachusetts $1.8M
Pharma Compliance Alert, September 24, 2008
Boehringer Ingelheim Roxane, Inc. (Roxane), a Columbus, OH based drug manufacturer, will pay Massachusetts $1.8 million for allegedly overpricing its drugs, according to a press release from the Massachusetts Attorney General’s Office.
Roxane allegedly inflated the prices it reported for its drugs, including lithium carbonate, azathioprine, Roxicet, Roxicodone, and ipratropium bromide. Medicaid based reimbursement on prices reported to national pharmaceutical price reporting services. The Commonwealth claimed the inflated prices led to overpayment by Medicaid.
Massachusetts sued 13 generic drug manufacturers for allegedly falsely inflating the prices they reported. Dey Pharmaceuticals, Barr Laboratories, Duramed Pharmaceuticals, and Ethex all previously settled with the Commonwealth.
Comments
0 comments on “Drug manufacturer to pay Massachusetts $1.8M ”
Related Products
-
Briefings on The Joint Commission
Briefings on The Joint Commission will help you with all of your accreditation and survey preparation needs. Every month...
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
The CMS Survey Coordinator's Handbook
There is no reason to struggle with CMS requirements. HCPro has teamed up with former contracted CMS surveyor Jeff Coleman...
-
Stark Law, 2nd edition: A user's guide to achieving compliance
This updated version of HCPro's Stark Law best seller, first published in 2005—and now co-authored by former CMS Stark...
-
The Compliance Officer's Handbook, 2nd Edition
This revised edition is packed with even more practical tools, case studies, tips and tools, sample audits, and sample...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- HIPAA Q&A: Level of encryption needed for email
- Case Management Monthly, June 2012
- Searched